Careers
Collaborate With Us
Collaborate With Us

Genomics

Unlock deeper biological insights with integrated multi-omics approaches—combining genomics, transcriptomics, proteomics, and metabolomics to drive precision medicine, accelerate discovery, and reveal complex disease mechanisms with unmatched clarity.

Human Genomics

Know More

Animal Genomics

Know More

Plant Genomics

Know More

Microbial Genomics

Know More

Human Genomics

Human genomics provides a powerful lens to understand the genetic foundation of health, development, and disease. By analyzing whole genomes or targeted regions, researchers and clinicians can uncover inherited disorders, predict disease risk, and tailor treatments to individual genetic profiles—paving the way for more effective and personalized healthcare solutions.

Oncology Screening

Precision Detection of Cancer-Driving Mutations

Next-Generation Sequencing (NGS) has revolutionized cancer screening and personalized therapy by enabling high-throughput, multi-gene analysis of tumor genomes. NGS panels (targeted, whole-exome, or transcriptome) identify somatic mutations, copy number variations (CNVs), gene fusions, and microsatellite instability (MSI) with high sensitivity, guiding diagnosis, prognosis, and targeted treatment. Key Mutations Detected by NGS in Oncology:
  • EGFR (L858R, T790M, exon 19 deletions) – Predictive of response to tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).
  • BRCA1/BRCA2 (pathogenic variants) – Determine eligibility for PARP inhibitors in ovarian and breast cancers.
  • KRAS (G12C/G12D/G12V) – Impacts therapy selection in colorectal, pancreatic, and lung cancers
  • BRAF V600E – Guides use of BRAF/MEK inhibitors in melanoma and colorectal cancer.
  • ALK/ROS1/NTRK fusions – Identify patients for TRK inhibitors or ALK inhibitors.
  • TP53 (loss-of-function mutations) – Associated with aggressive tumors and therapy resistance across multiple cancers.
  • PD-L1/MSI-H/TMB-H – Biomarkers for immune checkpoint inhibitors.
Clinical Applications:
  • Liquid biopsy (ctDNA-NGS) for minimal residual disease (MRD) monitoring.
  • Comprehensive genomic profiling (CGP) to match patients with clinical trials.
  • Hereditary cancer risk assessment (e.g., Lynch syndrome via MLH1/MSH2 mutations).
NGS-based oncology screening enables precision medicine, transforming "one-size-fits-all" chemotherapy into mutation-directed therapies for improved survival outcomes.
Neurology Screening

From neurodevelopmental disorders to neurodegenerative diseases, NGS facilitates precision neurology by identifying pathogenic variants that guide prognosis, therapeutic selection, and family counseling.

We screen these key mutations and many more for studying underlying neurological conditions:

  • APP, PSEN1, PSEN2 (Alzheimer’s disease) – Detects early-onset familial Alzheimer’s and guide anti-amyloid therapies
  • SNCA, LRRK2, GBA (Parkinson’s disease) – Identifies genetic risk factors and inform LRRK2 inhibitor trials
  • HTT (CAG repeats in Huntington’s disease) – Confirms diagnosis and predicts disease progression.
  • SCN1A, KCNQ2, CDKL5 (Epilepsy & developmental encephalopathies) – Guides anti-seizure medication selection.
  • DMD (Duchenne muscular dystrophy) – Detects deletions/duplications for exon-skipping therapies.
  • SOD1, C9ORF72, TARDBP (ALS) – Stratifies patients for gene-targeted therapies.
  • NF1, NF2 (Neurofibromatosis) – for diagnosing and monitoring tumor predisposition syndromes.

Clinical Approaches:

  • Whole-exome sequencing (WES) for undiagnosed neurogenetic disorders.
  • Gene panels (e.g., epilepsy, ataxia, leukodystrophy) for rapid diagnosis.
  • Mitochondrial genome sequencing for mitochondrial disorders (e.g., MELAS, Leigh syndrome).
  • Somatic mutation detection in brain tumors (e.g., IDH1/2 in gliomas).

NGS empowers early intervention, personalized treatment, and clinical trial enrollment, revolutionizing care for neurological conditions.

Reproductive Health Screening
Neo-Natal Screening
Newborn screening and neonatal genetics are interconnected fields focused on identifying and managing genetic disorders in newborns. Newborn screening tests, often blood-based, are used to detect a range of genetic and metabolic conditions, allowing for early intervention and potentially preventing severe health consequences.
Cardiovascular Screening
Precision Detection of Inherited and Acquired Cardiac Disorders: We provide comprehensive analysis of genetic mutations, structural variants, and somatic alterations linked to cardiac conditions - from inherited cardiomyopathies to drug-induced arrhythmias. These tests aid in early diagnosis, risk stratification, and personalized therapy. few of the conditions screened are: 1. Inherited Cardiac Conditions
  • Hypertrophic Cardiomyopathy (HCM): MYH7 (p.R403Q, p.R719W), MYBPC3 (truncating variants)
  • Dilated Cardiomyopathy (DCM): TTN (frameshift/nonsense mutations), LMNA (p.R644C, linked to sudden cardiac death)
  • Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): PKP2 (plakophilin-2 mutations), DSP (desmoplakin truncations)
2. Atherosclerosis & Lipid Disorders:
  • Familial Hypercholesterolemia (FH): LDLR (p.G592E, p.C681X), APOB/PCSK9 (gain-of-function variants).
And many more.....
Nephrology Screening
GeneInsight's battery of tests are aimed at detecting early signs of kidney dysfunction, monitoring ongoing kidney health, and identifying risk factors that can lead to chronic kidney disease (CKD) or other renal disorders.
Endocrinology Screening
Endocrinology Screening involves a series of diagnostic tests aimed at evaluating the function of the endocrine system—responsible for hormone production and regulation. Hormonal imbalances can affect metabolism, growth, reproduction, mood, and many other vital functions. Early detection through screening is essential for the management and prevention of endocrine disorders.Who Should Consider Endocrine Screening?

  • Individuals with symptoms of hormonal imbalance (fatigue, weight change, irregular periods, mood swings)
  • Those with a family history of endocrine disorders
  • Patients with diabetes, obesity, infertility, or osteoporosis
  • Individuals with autoimmune diseases
  • Women with PCOS or menopausal symptoms
  • Children with abnormal growth or puberty
Ophthalmology Screening
Genetic and Systemic Considerations in Eye Screening

Genetic Eye Disorders: NGS-based testing can identify inherited retinal diseases (e.g., retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease).

Systemic Diseases: Conditions like diabetes, hypertension, autoimmune diseases, and neurological disorders often have ocular manifestations, making eye screening a window into overall health.Who Should Get Screened?

Children: For early detection of amblyopia, strabismus, and refractive errors.

Adults (18–60): Every 1–2 years, especially if wearing glasses, contact lenses, or at risk.

Seniors (60+): Annually for glaucoma, cataracts, and macular degeneration.

People with Diabetes: Annual dilated eye exams to monitor for diabetic retinopathy.

Family History of Eye Disease: Earlier and more frequent screening for hereditary conditions.
Gastro-intestinal Screening
Genomic and Molecular Screening in GI Health
Genetic testing for inherited cancer syndromes like:
  • Lynch syndrome
  • Familial adenomatous polyposis (FAP)
NGS panels identify mutations that guide colorectal and pancreatic cancer treatment.

Microbiome analysis offers insights into gut health, inflammation, and personalized nutrition.

Who Should Be Screened?
  • Adults over 45 (for colon cancer)
  • People with family history of GI cancers or polyps
  • Individuals with chronic GI symptoms (e.g., bloating, diarrhea, bleeding, pain)
  • Patients with autoimmune conditions or liver disease
  • People with risk factors like smoking, alcohol use, obesity, or poor diet
Pulmonology Screening

Genetic and Molecular Screening

Genetic testing may be used for inherited lung conditions like:
  • Cystic fibrosis (CFTR gene mutations)
  • Alpha-1 antitrypsin deficiency
Molecular profiling in lung cancer (e.g., EGFR, ALK, KRAS mutations) guides personalized therapy decisions.

Who Should Undergo Pulmonology Screening?
  • Smokers or former smokers (especially for lung cancer)
  • Individuals with chronic cough, shortness of breath, or wheezing
  • Patients with a family history of lung disease or genetic respiratory disorders
  • Individuals with occupational exposure to dust, asbestos, or chemicals
  • People with autoimmune or systemic diseases affecting the lungs (e.g., lupus, rheumatoid arthritis)
Carrier Screening
Carrier screening is a genetic test that identifies if an individual carries a gene for a specific genetic disorder, even if they don't exhibit any symptoms themselves. This test is particularly important for family planning, as it can help individuals understand their risk of having a child with a genetic condition.
What it is:
  • Carrier screening is a type of genetic testing that looks for specific genetic variations (mutations) in a person's DNA.
  • A "carrier" has one copy of a gene that can cause a genetic disorder, but they don't develop the disorder themselves.
  • If both parents carry the same gene mutation, their child has a chance of inheriting two copies and developing the disorder
Immunology
Immunology Screening involves evaluating the immune system's function to detect immune deficiencies, autoimmune disorders, hypersensitivities, and chronic inflammatory conditions. These tests help identify whether the immune system is overactive, underactive, or misdirected, and are essential for early diagnosis, personalized treatment, and long-term disease management. Who Should Consider Immunology Screening?
  • Individuals with recurrent infections
  • Patients with chronic fatigue, unexplained inflammation, or fevers
  • Family history of autoimmune or immunodeficiency disorders
  • People with allergies, asthma, or eczema
  • Those on immunosuppressive therapy (e.g., chemotherapy, biologics) Benefits of Immunology Screening
  • Early detection of immune dysfunction or autoimmune conditions
  • Personalized immune-modulating treatment
  • Improved management of allergies, chronic inflammation, and immune suppression
  • Risk assessment for genetic immune disorders
Infectious Diseases
Infectious Disease Screening involves diagnostic tests to detect active or latent infections caused by bacteria, viruses, fungi, or parasites. These screenings are vital for early detection, treatment, prevention of transmission, and public health monitoring. Routine infectious disease screening is particularly important for high-risk individuals, travelers, pregnant women, and immunocompromised patients. Molecular and Genomic Tools

PCR and RT-PCR: High-sensitivity tests for early and precise pathogen detection.

Next-Generation Sequencing (NGS):
  • Detects emerging or rare pathogens.
  • Tracks mutations and antimicrobial resistance (AMR).
Metagenomic sequencing: Useful in unexplained infections or polymicrobial disease. Molecular and Genomic Tools PCR and RT-PCR: High-sensitivity tests for early and precise pathogen detection.

Next-Generation Sequencing (NGS):
  • Detects emerging or rare pathogens.
  • Tracks mutations and antimicrobial resistance (AMR).
Rare Diseases
Next-Generation Sequencing (NGS) has revolutionized the diagnosis and study of rare diseases, offering a powerful tool for identifying genetic causes, understanding disease mechanisms, and facilitating the development of targeted therapies. Rare diseases, by definition, affect a small proportion of the population, making them challenging to diagnose and treat.

In many cases, these conditions are caused by genetic mutations that are difficult to identify using traditional diagnostic methods, such as single-gene testing or biochemical assays. NGS provides a high-throughput, comprehensive approach to identify novel mutations, uncover genetic variants, and enhance our understanding of these complex conditions
Personalized Wellness (PGx)
Pharmacogenomics is a branch of precision medicine that combines pharmacology (the study of drugs) with genomics (the study of genes and their functions). By studying how genetic variations impact drug metabolism, efficacy, and side effects, PGx allows for the development of more individualized and effective treatment strategies.

Key Aspects of PGx:

Drug Metabolism: Genetic variations can influence how quickly or slowly a person metabolizes a drug, impacting its effectiveness and risk of side effects.

Drug Efficacy: Some individuals may have genetic variants that make them more or less responsive to a particular drug.

Side Effects: Genetics can play a role in how likely a person is to experience adverse drug reactions, helping to tailor drug choices.

Animal Genomics

Animal genomics is the study of the genetic makeup of animals, focusing on the structure, function, and variation of their DNA. Using advanced tools like next-generation sequencing (NGS) and bioinformatics, researchers can analyze genomes to uncover the molecular basis of traits, behaviors, and diseases. This field has transformative applications in agriculture, conservation, and medicine, helping improve animal health, breeding strategies, and biodiversity preservation.

Applications of Animal Genomics

Livestock Improvement
Selective Breeding: Animal genomics helps identify genes linked to traits like disease resistance, reproductive performance, and growth rate. This allows for genomic selection in breeding programs, improving livestock productivity and efficiency.

Disease Resistance: Genomic tools can identify animals with natural resistance to diseases (e.g., foot-and-mouth disease or avian influenza), leading to healthier herds and flocks.

Animal Welfare: Identifying genetic factors associated with stress, behavior, and health issues can improve livestock well-being.
Conservation Biology
Genetic Diversity Assessment: Genomic studies help assess the genetic diversity of endangered species, which is crucial for effective conservation management and making informed decisions about breeding programs.

Tracking Population Health: Monitoring genetic health in wild populations can help identify at-risk species or populations and assess how environmental changes or human activities affect genetic variability.
Veterinary Medicine:
Genetic Disease Diagnosis: Animal genomics aids in identifying genetic mutations responsible for inherited diseases in pets and livestock. Early diagnosis allows for better management and treatment plans.

Personalized Medicine: Genomic data can tailor treatments to individual animals, improving the effectiveness of interventions and therapies.
Understanding Animal Biology:
Behavioral Genetics: Genomic analysis can uncover the genetic factors underlying behaviors in animals, ranging from feeding habits to mating preferences, helping researchers understand evolutionary processes.

Functional Genomics: Studying the regulation of gene expression and how genes control development, metabolism, and other biological processes helps us understand animal biology more deeply.
Food Security and Sustainability
Enhancing Animal Products: Through genetic studies, animal genomics can help enhance the quality and nutritional content of animal-derived products like milk, meat, and eggs, contributing to global food security.

Sustainable Practices: By understanding genetic traits related to feed efficiency and environmental adaptation, animal genomics can contribute to more sustainable agricultural practices.
Food Security and Sustainability
Enhancing Animal Products: Through genetic studies, animal genomics can help enhance the quality and nutritional content of animal-derived products like milk, meat, and eggs, contributing to global food security.

Sustainable Practices: By understanding genetic traits related to feed efficiency and environmental adaptation, animal genomics can contribute to more sustainable agricultural practices.
Biomedical Research:
Model Organisms: Many animals (e.g., mice, zebrafish) are used as model organisms to study human diseases. Animal genomics allows for better understanding of disease pathways and the development of new treatments.

Transgenic Animals: Genetically modified animals are used to study gene function or produce pharmaceuticals (e.g., genetically engineered goats producing therapeutic proteins in their milk).

Plant Genomics

Plant genomics is the study of plant DNA, genes, and genetic processes to understand traits, development, and responses to the environment. Through advanced techniques like next-generation sequencing (NGS) and genome-wide association studies (GWAS), scientists can identify the genetic foundations of important plant characteristics. This research supports innovations in agriculture, enhances biodiversity conservation, and promotes more sustainable and resilient food systems.

Applications of Plant Genomics:

Crop Improvement:
Disease Resistance: By identifying genes responsible for resistance to plant pathogens, genomics helps develop crops that are more resistant to diseases like rust, blight, and viral infections, reducing the need for chemical pesticides.

Drought and Stress Tolerance: Genomics helps identify genetic factors that confer resistance to environmental stresses, such as drought, high salinity, and extreme temperatures. This is particularly important as climate change makes crop survival under stress conditions more challenging.

High Yield and Nutritional Quality: Through genome analysis, plant breeders can identify traits associated with higher crop yields, improved nutritional content (e.g., biofortified crops like golden rice with increased vitamin A), and better adaptation to local environments.
Improving Crop Resilience:
Climate Change Adaptation: Plant genomics enables the development of crops that can thrive under changing climatic conditions, such as crops with enhanced heat tolerance or those that require less water, helping to secure global food supply amid climate change.

Soil Fertility and Nitrogen Fixation: Genomics can help develop plants that have better root systems or can enhance nitrogen fixation, reducing the need for synthetic fertilizers and promoting more sustainable farming practices.
Plant Breeding:
Marker-Assisted Selection (MAS): By associating specific genetic markers with desirable traits, plant genomics allows for marker-assisted breeding, which accelerates the development of new crop varieties with improved traits.

Genome-Wide Association Studies (GWAS): These studies identify genetic variants linked to specific traits, helping plant breeders to select for traits like drought resistance or disease tolerance more efficiently.
Conservation of Plant Species:
Biodiversity Preservation: Genomics helps conserve plant biodiversity by identifying unique genetic traits in endangered plant species. This can inform breeding or restoration programs aimed at preserving genetic diversity in natural populations.

Reforestation: In forestry, genomics is used to select and breed tree species that are more resilient to pests, diseases, and environmental stress, aiding in large-scale reforestation and afforestation efforts.
Phytoremediation and Sustainable Agriculture:
Hytoremediation: Genomics can be used to identify plants that can clean up contaminated soils by absorbing pollutants like heavy metals or pesticides. This process, known as phytoremediation, plays an important role in environmental cleanup and sustainable agriculture.

Sustainable Farming Practices: By improving plant varieties to require less chemical input (e.g., fewer fertilizers and pesticides), genomics supports the development of more sustainable farming practices, reducing agriculture's ecological footprint.
Plant Functional Genomics:
Gene Function and Pathways: Understanding the function of individual genes and their role in plant metabolism, development, and stress responses helps scientists engineer plants with specific beneficial traits, such as faster growth or improved disease resistance.

Metabolomics: Combining genomics with metabolomics (the study of metabolites) allows for a better understanding of plant secondary metabolites (e.g., flavonoids, alkaloids), which have applications in pharmaceuticals, food, and agriculture.
Food Security:
Staple Crop Enhancement: Plant genomics can help enhance staple crops like rice, wheat, and maize, which are critical to global food security. By improving their nutritional content, disease resistance, and yield, genomics plays a pivotal role in feeding a growing global population.

Biofortification: Genomic tools are used to develop crops with enhanced nutrient content, such as iron-rich rice or vitamin A-enriched maize, helping combat malnutrition in developing regions.
Plant-Microbe Interactions:
Symbiosis and Soil Health: Genomics can help understand how plants interact with beneficial microbes, such as nitrogen-fixing bacteria or mycorrhizal fungi, to promote healthier and more sustainable crops.

Pest and Pathogen Resistance: Understanding the plant's genetic responses to microbial infections enables the development of plants that can better resist or tolerate attacks from pests and pathogens.

Plant genomics has the potential to revolutionize agriculture, enhance food security, and ensure sustainability in the face of global challenges like climate change, population growth, and environmental degradation. By unlocking the genetic blueprint of plants, scientists can create crops that are more resilient, nutritious, and environmentally friendly, ultimately leading to a more sustainable and productive agricultural system.

Microbial Genomics

Microbial genomics studies the DNA of microorganisms like bacteria, fungi, and viruses using next-generation sequencing (NGS). It helps reveal their roles in health, agriculture, and the environment, with applications in medicine, biotechnology, and ecology.

Applications of Microbial Genomics

Healthcare and Medicine:
Pathogen Identification and Surveillance: Genomic sequencing enables rapid and precise identification of pathogens (e.g., bacteria, viruses, fungi) causing infectious diseases. It is particularly useful in outbreak investigation, where genomic analysis helps track the spread of infectious agents, such as in COVID-19, antibiotic-resistant bacteria, and tuberculosis.

Antibiotic Resistance: By sequencing the genomes of antibiotic-resistant microbes, researchers can identify the genes responsible for resistance and track the emergence of new resistant strains. This helps in developing strategies to combat resistance and improve treatment regimens.

Microbiome Research: Microbial genomics is fundamental to studying the human microbiome (the collection of microorganisms living in and on the human body). Understanding microbial communities in the gut, skin, and other areas can provide insights into health, diseases, and personalized medicine.
Agriculture:
Soil Microbiomes: Genomic analysis of soil microbes helps in understanding soil health, fertility, and the complex interactions between plants and soil microorganisms. This can enhance crop growth, improve nutrient cycling, and reduce the need for synthetic fertilizers.

Biological Control Agents: Microbial genomics is used to identify beneficial microbes that can act as natural pesticides or biological control agents to manage agricultural pests and diseases.

Genetically Modified Crops: Microbial genomics also plays a role in engineering microorganisms to produce useful compounds that can be used in genetically modified crops, such as improving plant resistance to drought or pests.
Environmental Sciences:
Bioremediation: Microbial genomics is essential for understanding how microbes can be used to degrade pollutants in the environment, a process known as bioremediation. By identifying genes involved in the breakdown of contaminants, scientists can engineer or promote microorganisms to clean up oil spills, heavy metals, or pesticides.

Wastewater Treatment: Genomic tools help identify and optimize microbial communities involved in wastewater treatment processes. Understanding these communities helps improve the efficiency of nutrient removal, toxin degradation, and overall treatment.

Climate Change and Carbon Sequestration: Microbial genomics can help identify microbes involved in carbon cycling and greenhouse gas emissions, aiding in the development of strategies to mitigate climate change.
Industrial Applications:
Fermentation and Bioprocessing: Microbial genomics is crucial for improving the efficiency of industrial fermentation processes, which are used in the production of food, beverages, biofuels, and pharmaceuticals.

Biofuel Production: Microbial genomes are analyzed to discover microbes that can produce biofuels like ethanol, methane, or butanol more efficiently. Engineered microbes can be developed for large-scale biofuel production.

Enzyme Production: Many industrial processes rely on enzymes produced by microbes. Genomic analysis helps in identifying microbial strains that produce high-yielding, efficient enzymes for various applications, such as detergents, textiles, or paper production.
Food and Beverage Industry:
Probiotics and Fermented Foods: Microbial genomics helps identify and optimize microorganisms used in the production of probiotics and fermented foods like yogurt, cheese, kimchi, and sauerkraut. Understanding the genome of Lactobacillus species, for example, can lead to better probiotic strains with enhanced health benefits.

Food Safety: Genomic tools help identify foodborne pathogens (like Salmonella, E. coli, and Listeria) and track outbreaks more effectively. This is crucial for ensuring food safety and protecting public health.